Cargando…

Monoclonal antibodies targeting the influenza virus N6 neuraminidase

Influenza A viruses are a diverse species that include 16 true hemagglutinin (HA) subtypes and 9 true neuraminidase (NA) subtypes. While the antigenicity of many HA subtypes is reasonably well studied, less is known about NA antigenicity, especially when it comes to non-human subtypes that only circ...

Descripción completa

Detalles Bibliográficos
Autores principales: Strohmeier, Shirin, Amanat, Fatima, Carreño, Juan Manuel, Krammer, Florian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363587/
https://www.ncbi.nlm.nih.gov/pubmed/35967389
http://dx.doi.org/10.3389/fimmu.2022.944907
_version_ 1784764958207115264
author Strohmeier, Shirin
Amanat, Fatima
Carreño, Juan Manuel
Krammer, Florian
author_facet Strohmeier, Shirin
Amanat, Fatima
Carreño, Juan Manuel
Krammer, Florian
author_sort Strohmeier, Shirin
collection PubMed
description Influenza A viruses are a diverse species that include 16 true hemagglutinin (HA) subtypes and 9 true neuraminidase (NA) subtypes. While the antigenicity of many HA subtypes is reasonably well studied, less is known about NA antigenicity, especially when it comes to non-human subtypes that only circulate in animal reservoirs. The N6 subtype NAs are mostly found in viruses infecting birds. However, they have also been identified in viruses that infect mammals, such as swine and seals. More recently, highly pathogenic H5N6 subtype viruses have caused rare infections and mortality in humans. Here, we generated murine mAbs to the N6 NA, characterized their breadth and antiviral properties in vitro and in vivo and mapped their epitopes by generating escape mutant viruses. We found that the antibodies had broad reactivity across the American and Eurasian N6 lineages, but relatively little binding to the H5N6 NA. Several of the antibodies exhibited strong NA inhibition activity and some also showed activity in the antibody dependent cellular cytotoxicity reporter assay and neutralization assay. In addition, we generated escape mutant viruses for six monoclonal antibodies and found mutations on the lateral ridge of the NA. Lastly, we observed variable protection in H4N6 mouse challenge models when the antibodies were given prophylactically.
format Online
Article
Text
id pubmed-9363587
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93635872022-08-11 Monoclonal antibodies targeting the influenza virus N6 neuraminidase Strohmeier, Shirin Amanat, Fatima Carreño, Juan Manuel Krammer, Florian Front Immunol Immunology Influenza A viruses are a diverse species that include 16 true hemagglutinin (HA) subtypes and 9 true neuraminidase (NA) subtypes. While the antigenicity of many HA subtypes is reasonably well studied, less is known about NA antigenicity, especially when it comes to non-human subtypes that only circulate in animal reservoirs. The N6 subtype NAs are mostly found in viruses infecting birds. However, they have also been identified in viruses that infect mammals, such as swine and seals. More recently, highly pathogenic H5N6 subtype viruses have caused rare infections and mortality in humans. Here, we generated murine mAbs to the N6 NA, characterized their breadth and antiviral properties in vitro and in vivo and mapped their epitopes by generating escape mutant viruses. We found that the antibodies had broad reactivity across the American and Eurasian N6 lineages, but relatively little binding to the H5N6 NA. Several of the antibodies exhibited strong NA inhibition activity and some also showed activity in the antibody dependent cellular cytotoxicity reporter assay and neutralization assay. In addition, we generated escape mutant viruses for six monoclonal antibodies and found mutations on the lateral ridge of the NA. Lastly, we observed variable protection in H4N6 mouse challenge models when the antibodies were given prophylactically. Frontiers Media S.A. 2022-07-27 /pmc/articles/PMC9363587/ /pubmed/35967389 http://dx.doi.org/10.3389/fimmu.2022.944907 Text en Copyright © 2022 Strohmeier, Amanat, Carreño and Krammer https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Strohmeier, Shirin
Amanat, Fatima
Carreño, Juan Manuel
Krammer, Florian
Monoclonal antibodies targeting the influenza virus N6 neuraminidase
title Monoclonal antibodies targeting the influenza virus N6 neuraminidase
title_full Monoclonal antibodies targeting the influenza virus N6 neuraminidase
title_fullStr Monoclonal antibodies targeting the influenza virus N6 neuraminidase
title_full_unstemmed Monoclonal antibodies targeting the influenza virus N6 neuraminidase
title_short Monoclonal antibodies targeting the influenza virus N6 neuraminidase
title_sort monoclonal antibodies targeting the influenza virus n6 neuraminidase
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363587/
https://www.ncbi.nlm.nih.gov/pubmed/35967389
http://dx.doi.org/10.3389/fimmu.2022.944907
work_keys_str_mv AT strohmeiershirin monoclonalantibodiestargetingtheinfluenzavirusn6neuraminidase
AT amanatfatima monoclonalantibodiestargetingtheinfluenzavirusn6neuraminidase
AT carrenojuanmanuel monoclonalantibodiestargetingtheinfluenzavirusn6neuraminidase
AT krammerflorian monoclonalantibodiestargetingtheinfluenzavirusn6neuraminidase